Biotech as a Service
Accelerate your early Drug Development
Our operating model
A standardized playbook built for execution
Early‑stage biotech has changed. Programs are built with lean core teams, early outsourcing, and constant capital pressure.
What hasn’t changed fast enough is how execution is structured. Most delays, rework, and risk don’t come from science. They come from rebuilding governance, quality systems, and operating rules from scratch, and adapting them again and again.
ACLRT.Bio was created to close this gap. Our model standardizes execution so our team can focus on what truly drives value: advancing your asset to its next inflection point.
The core principle: execution without setup
ACLRT.Bio operates with a ready‑to‑deploy, repeatable execution backbone.
When we engage on a program, nothing starts from zero. Governance, quality, operating rules and infrastructure are already in place.
This removes learning curves, setup time, unnecessary friction, and allows execution to start immediately.
What is standardized:
1. Governance and decision architecture
-
Clear decision logic across functions, all aligned from day one
-
Defined decision cadence
-
Explicit ownership and escalation paths
2. Vendor governance and orchestration
-
Structured CRO / CDMO oversight and management system
-
Unified expectations on outputs, timelines, and escalation
-
One coherent program narrative across all external partners
-
Vendors execute within aligned and common scopes
3. Quality and compliance system
-
Ready-to-plug GxP-compliant quality system
-
Consistent documentation management
-
Built‑in readiness for IND / CTA, authority interactions, and trial sponsorship
4. Shared and agile IT infrastructure
-
Software and tools selected for agility, speed of execution, and low operational friction
-
Seamless integration across functions to support real‑time execution and decision‑making
-
Selective and conscious use of AI where it meaningfully accelerates analysis, coordination, or decision preparation
5. Execution-Ready Team Model
-
One team operating in a well-known, proven execution environment
-
Shared execution backbone (vocabulary, templates, and execution rituals)
-
Defined role‑based training paths, including regarding quality and compliance
-
Continuous learning loops that improve execution without resetting the operating model
What remains program-specific:
Standardized does not mean one-size-fits-all.
It applies to how work is run and decisions are made, never to scientific choices.
Scientific differentiation remains fully program‑driven:
-
modality and platform
-
target biology
-
translational strategy
-
clinical hypothesis
-
scientific risk profile
This separation protects innovation while reducing execution friction.